Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: Brief report from an integrated electronic health records pilot study

Julie A. Schmittdiel, Sara R. Adams, Jodi Segal, Marie R. Griffin, Christianne L. Roumie, Kris Ohnsorg, Richard W. Grant, Patrick J. O'Connor

Research output: Contribution to journalArticle

Abstract

OBJECTIVE This study uses novel methods to examine the frequency of diagnosis and treatment of prediabetes in real-world clinical settings using electronic health record (EHR) data. RESEARCH DESIGN AND METHODS We identified a cohort of 358,120 adults with incident prediabetes (fasting plasma glucose [FPG] 100-125 mg/dL or glycated hemoglobin 5.7-6.4% [39-46 mmol/ mol]) between 2006 and 2010 and examined rates of diagnosis and treatment in the 6 months after identification. RESULTS In the 6months after identification of prediabetes, 18%of patients had their blood glucose levels retested; 13% received a physician diagnosis of prediabetes/hyperglycemia; 31.0% had prediabetes, diabetes, or lifestyle documented in the clinical notes; and <0.1% initiated metformin. Among patients with FPG 120-125 mg/dL, 31% were retested; metformin initiation remained <1%. CONCLUSIONS Documented rates of follow-up and treatment for prediabetes are low. EHR data may be a valuable tool to improve identification and treatment of prediabetes in the U.S.

Original languageEnglish (US)
Pages (from-to)565-568
Number of pages4
JournalDiabetes care
Volume37
Issue number2
DOIs
StatePublished - Feb 1 2014

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this